38304-91-5 Purity
---
If you have any other questions or need other size, please get a quote.
Specification
A novel conjugate was prepared using deoxycholic acid (DOCA), O-carboxymethylated chitosan (OCMC) and folic acid (FA), which can be used in cancer-targeted drug delivery systems.
Synthesis of Conjugates
· Modification of OCMC with DOCA: OCMC was hydrophobically modified with DOCA to obtain a new amphiphilic polymer. To activate the carboxylic acid groups of DOCA in dried DMSO, equal amounts of EDC and NHS were added into the solution, which allowing the formation of an amide linkage by the reaction with primary amino groups in OCMC.
· Synthesis of DOMC-FA conjugates: Folate was attached to the surface amino groups of DOMC via a carbodiimide reaction.
The molecular formula of deoxycholic acid is C24H40O4.
The molecular weight of deoxycholic acid is 392.6 g/mol.
Deoxycholic acid is described as a bile acid that is 5beta-cholan-24-oic acid substituted by hydroxy groups at positions 3 and 12 respectively.
Deoxycholic acid serves as a human blood serum metabolite.
The IUPAC name of deoxycholic acid is (4R)-4-[(3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid.
When injected subcutaneously, deoxycholic acid disrupts cell membranes in adipocytes and destroys fat cells in that tissue.
Deoxycholic acid was approved by the FDA for the treatment of submental fat in April 2015.
Deoxycholic acid is marketed under the brand name Kybella by Kythera Biopharma.
The Canonical SMILES representation of deoxycholic acid is CC(CCC(=O)O)C1CCC2C1(C(CC3C2CCC4C3(CCC(C4)O)C)O)C.
Deoxycholic acid demonstrates a relative selectivity for fat over other tissues as a naturally occurring bile acid.